Table 5. Hazard ratios for adenoma recurrence, according to baseline patient and adenoma characteristics (447 followed up participants).
Univariate analysis* | Multivariate analysis | |||||
Characteristic | Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value |
Gender | ||||||
female | 1 | reference | 1 | reference | ||
male | 0.63 | 0.44 to 0.90 | 0.01 | 0.71 | 0.48 to 1.04 | 0.08 |
Age (per 10 years) | 1.12 | 0.95 to 1.31 | 0.16 | 1.07 | 0.89 to 1.28 | 0.48 |
Aspirin use | ||||||
no | 1 | reference | 1 | reference | ||
yes | 1.68 | 0.97 to 2.92 | 0.07 | 1.38 | 0.77 to 2.48 | 0.27 |
Number (per 1 increase) | 1.20 | 1.06 to 1.35 | <10−2 | 1.17 | 1.03 to 1.34 | 0.01 |
Advanced adenoma | ||||||
no | 1 | reference | 1 | reference | ||
yes | 1.32 | 0.95 to 1.84 | 0.10 | 1.32 | 0.93 to 1.88 | 0.12 |
variables that had a p value<0.20.